SVA [SINOVAC BIOTECH] SC 13D/A: SCHEDULE 13D CUSIP No. P8696W104 Page 2 of
[SCHEDULE 13D CUSIP No. P8696W104 Page 2 of 6 Pages]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[/CORRECTION/-Sinovac Biotech Ltd. , 56.1 , 55.6% , In the news release, " 62.6% 75.2% , 60.3% 72.9% And the second sentence of the third paragraph from the section titled “Financial Review for the Nine Months Period Ended September 30, 2011” should read as “After deducting depreciation of land use rights, amortization of licenses, permits, the gross margin was 58.6%] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]
SVA [SINOVAC BIOTECH] 6-K: /CORRECTION/-Sinovac Biotech Ltd. , 56.1 , 55.6% ,
[/CORRECTION/-Sinovac Biotech Ltd. , 56.1 , 55.6% , In the news release, " 62.6% 75.2% , 60.3% 72.9% And the second sentence of the third paragraph from the section titled “Financial Review for the Nine Months Period Ended September 30, 2011” should read as “After deducting depreciation of land use rights, amortization of licenses, permits, the gross margin was 58.6%] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]
SVA [SINOVAC BIOTECH] SC 13D/A: (Original Filing)
[CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) þ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC 5]
SVA [SINOVAC BIOTECH] SC 13D/A: CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS
[CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) þ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC 5]
SVA [SINOVAC BIOTECH] SC 13D/A: (Original Filing)
[CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) þ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC 5]
SVA [SINOVAC BIOTECH] SC 13D/A: (Original Filing)
[CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) þ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC 5]
SVA [SINOVAC BIOTECH] SC 13D/A: CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS
[CUSIP No. P8696W104 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) þ (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) WC 5]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Reports Unaudited Second Quarter 2011 Financial Results - Conference call scheduled for Friday, August 12, 2011 at 8:00 AM EDT – – Sinovac Biotech Ltd. ( today its unaudited second Beijing – August 12, 2011 Second Quarter 2011 Financial Highlights · Sales increased 52.5% year-over-year to $15.7 million, compared to $10.3 million. · Net income attributable to shareholder reached] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x ¨ Form 20-F SINOVAC BIOTECH LTD. 6-K 1 v232192_6k.htm FORM 6-K]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Second Quarter 2011 Financial Results
[Sinovac Reports Unaudited Second Quarter 2011 Financial Results - Conference call scheduled for Friday, August 12, 2011 at 8:00 AM EDT – – Sinovac Biotech Ltd. ( today its unaudited second Beijing – August 12, 2011 Second Quarter 2011 Financial Highlights · Sales increased 52.5% year-over-year to $15.7 million, compared to $10.3 million. · Net income attributable to shareholder reached] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x ¨ Form 20-F SINOVAC BIOTECH LTD. 6-K 1 v232192_6k.htm FORM 6-K]
